Albireo Pharma, Inc.
ALBO · NASDAQ
9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $222 | $181 | $217 | $248 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $2 | $2 | $1 | $3 |
| Inventory | $3 | $2 | $2 | $0 |
| Other Curr. Assets | $3 | $3 | $2 | $12 |
| Total Curr. Assets | $239 | $196 | $229 | $269 |
| Property Plant & Equip (Net) | $1 | $1 | $1 | $1 |
| Goodwill | $17 | $17 | $17 | $17 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $64 | $15 | $14 | $15 |
| Total NC Assets | $82 | $33 | $33 | $33 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $321 | $229 | $261 | $302 |
| Liabilities | – | – | – | – |
| Payables | $7 | $5 | $6 | $7 |
| Short-Term Debt | $0 | $10 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $31 | $28 | $25 | $39 |
| Total Curr. Liab. | $38 | $44 | $32 | $45 |
| LT Debt | $0 | $0 | $10 | $10 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $183 | $72 | $71 | $71 |
| Total NC Liab. | $183 | $72 | $82 | $81 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $221 | $115 | $113 | $126 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$421 | -$383 | -$343 | -$301 |
| AOCI | $8 | $8 | $8 | $1 |
| Other Equity | $513 | $488 | $483 | $475 |
| Total Equity | $100 | $114 | $148 | $176 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $321 | $229 | $261 | $302 |
| Net Debt | -$222 | -$171 | -$207 | -$238 |